120 related articles for article (PubMed ID: 10622325)
21. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
22. Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapy.
Guérard F; Gestin JF; Brechbiel MW
Cancer Biother Radiopharm; 2013 Feb; 28(1):1-20. PubMed ID: 23075373
[TBL] [Abstract][Full Text] [Related]
23. Overcoming the obstacles to clinical evaluation of (211)At-labeled radiopharmaceuticals.
Wilbur DS
J Nucl Med; 2001 Oct; 42(10):1516-8. PubMed ID: 11585866
[No Abstract] [Full Text] [Related]
24. Can tumor oxygenation be improved by reducing cellular oxygen consumption.
Thews O; Kelleher DK; Hummel M; Vaupel P
Adv Exp Med Biol; 1999; 471():525-32. PubMed ID: 10659186
[No Abstract] [Full Text] [Related]
25. 76Br-MBBG, a PET radiotracer to investigate the norepinephrine neurological and vesicular transproters in the heart.
Maziere B; Valette H; Loc'h C
Nucl Med Biol; 1995 Nov; 22(8):1049-52. PubMed ID: 8998465
[No Abstract] [Full Text] [Related]
26. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
[TBL] [Abstract][Full Text] [Related]
27. Proceedings of the 1st International Symposium on Radionuclide Therapy and Radiopharmaceutical Dosimetry. September 4-8, 2004, Helsinki, Finland.
Cancer Biother Radiopharm; 2005 Feb; 20(1):41-118. PubMed ID: 15778578
[No Abstract] [Full Text] [Related]
28. Astatine-211 imaging by a Compton camera for targeted radiotherapy.
Nagao Y; Yamaguchi M; Watanabe S; Ishioka NS; Kawachi N; Watabe H
Appl Radiat Isot; 2018 Sep; 139():238-243. PubMed ID: 29864741
[TBL] [Abstract][Full Text] [Related]
29. Anti-cancer radiopharmaceuticals.
Hoefnagel CA
Anticancer Drugs; 1991 Apr; 2(2):107-32. PubMed ID: 1958857
[TBL] [Abstract][Full Text] [Related]
30. A "pheo" lurks: novel approaches for locating occult pheochromocytoma.
Pacak K; Goldstein DS; Doppman JL; Shulkin BL; Udelsman R; Eisenhofer G
J Clin Endocrinol Metab; 2001 Aug; 86(8):3641-6. PubMed ID: 11502790
[TBL] [Abstract][Full Text] [Related]
31. [131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter.
McCluskey AG; Boyd M; Ross SC; Cosimo E; Clark AM; Angerson WJ; Gaze MN; Mairs RJ
Clin Cancer Res; 2005 Nov; 11(21):7929-37. PubMed ID: 16278418
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
33. Radionuclide cancer therapy.
Hoefnagel CA
Ann Nucl Med; 1998 Apr; 12(2):61-70. PubMed ID: 9637275
[TBL] [Abstract][Full Text] [Related]
34. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
35. Radiation physics and genetic targeting: new directions for radiotherapy. The Douglas Lea Lecture 1999.
Wheldon TE
Phys Med Biol; 2000 Jul; 45(7):R77-95. PubMed ID: 10943913
[TBL] [Abstract][Full Text] [Related]
36. [Targeted radionuclide therapy for castration-resistant prostate cancer].
Nakamura K; Ohga S; Sasaki T; Baba S; Honda H
Nihon Rinsho; 2014 Dec; 72(12):2181-5. PubMed ID: 25518355
[TBL] [Abstract][Full Text] [Related]
37. [Radionuclide therapy for bone metastases: new opportunities].
Krylov VV; Kochetova TY; Voloznev LV
Vopr Onkol; 2015; 61(1):14-9. PubMed ID: 26016139
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiological analysis of transporter function.
DeFelice LJ; Galli A
Adv Pharmacol; 1998; 42():186-90. PubMed ID: 9327875
[No Abstract] [Full Text] [Related]
39. Horizons in radionuclide therapy: 1985 update.
Beierwaltes WH
J Nucl Med; 1985 Apr; 26(4):421-7. PubMed ID: 3884750
[TBL] [Abstract][Full Text] [Related]
40. Tails of serotonin and norepinephrine transporters: deletions and chimeras retain function.
Blakely RD; Moore KR; Qian Y
Soc Gen Physiol Ser; 1993; 48():283-300. PubMed ID: 8503051
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
